ANDA 85928, held by Abbott. Hydrocortisone Sodium Succinate.
As of Nov 16, 2026, ANDA 85928 (A-Hydrocort), held by Abbott, was first approved by FDA on Mar 28, 1978, with 0 approved supplements and 0 published complete response letters.
| Date | Submission | Status | Documents |
|---|---|---|---|
| Mar 28, 1978 | Original application | Approved | None posted |
| Product | Active ingredient | Marketing |
|---|---|---|
| A-HydrocortEQ 100MG BASE/VIAL ยท injectable;injection | Hydrocortisone Sodium Succinate | Discontinued |
Approvals, supplements, products and documents come from FDA's Drugs@FDA data files, refreshed daily; Drugs@FDA lists approved applications only. Complete response letters are FDA's published letters. Drugs@FDA and FDA complete response letters